Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study

作者：Zhengbo Song, Ziming Li, Yiping Zhang, Pingli Wang, Liyan Jiang, Yanqiu Zhao, Jianying Zhou, Xicheng Wang, Zhuang Wu, Jianhua Shi, Dingzhi Huang, Xiaomin Dang, Shundong Cang, Yi Gong, Jin Shi, Weiwei Li, Xiaorong Dong, Junping Zhang, Mingfang Zhao, Xiangjiao Meng, Xuewen Liu, Jian Fang, Ping Wu, Junguo Lu, Liangming Zhang, Junquan Yang, Xiang Wang, Hui Luo, Jiuwei Cui, Zhihong Zhang, Jing Wang, Gaofeng Li, Lin Wu, Yu Yan, Yong Fang, Dongqing Lv, Weihua Yang, Lingxiang Chen, Nong Yang, Kunyan Li, Rui Ma, Mingxi Wang, Huan Zhou, Sheng Hu, Qingshan Li, Zhixiang Zhuang, Baoshan Cao, Wei Zhu, Chunwei Xu, Wenjia Wang, Ziyong Xiang, Zhe Shi, Yaolin Wang, Ling Zhang, Shun Lu · 发表于：European Journal of Cancer · 年份：2025 · DOI：10.1016/j.ejca.2025.116153 · 被引用次数：5 · 研究领域：Lung Cancer Treatments and Mutations、Protein Kinase Regulation and GTPase Signaling、Lung Cancer Research Studies